Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients.


Journal

NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891

Informations de publication

Date de publication:
18 Dec 2020
Historique:
received: 03 06 2020
accepted: 12 11 2020
entrez: 19 12 2020
pubmed: 20 12 2020
medline: 20 12 2020
Statut: epublish

Résumé

Currently, there are no markers to identify patients with liver-only or liver-dominant metastases that would benefit from hepatic surgery. Here we characterized histopathological growth patterns (HGPs) of liver metastases in a consecutive series of 36 breast cancer patients who underwent hepatic surgery. Survival analyses showed that the presence of a desmoplastic HGP in the liver metastases (a rim of fibrous tissue separating cancer cells from the liver parenchyma, present in 20 (56%) patients) is independently associated with favorable progression-free and overall survival when compared with the replacement HGP (cancer cells growing into the liver parenchyma, present in 16 (44%) patients).

Identifiants

pubmed: 33339824
doi: 10.1038/s41523-020-00209-1
pii: 10.1038/s41523-020-00209-1
pmc: PMC7749172
doi:

Types de publication

Journal Article

Langues

eng

Pagination

64

Références

Ann Surg Oncol. 2019 Sep;26(9):2812-2820
pubmed: 31147988
NPJ Breast Cancer. 2020 Dec 18;6(1):64
pubmed: 33339824
Br J Cancer. 2020 Jul;123(2):196-206
pubmed: 32418992
Clin Breast Cancer. 2017 Jul;17(4):256-265
pubmed: 28196771
Breast Cancer. 2019 Mar;26(2):138-146
pubmed: 30324552
Nat Med. 2016 Nov;22(11):1294-1302
pubmed: 27748747
Clin Exp Metastasis. 2019 Aug;36(4):311-319
pubmed: 31134394
Ann Oncol. 2018 Aug 1;29(8):1634-1657
pubmed: 30032243
Br J Cancer. 2020 May;122(10):1518-1524
pubmed: 32205863
Angiogenesis. 2019 May;22(2):355-368
pubmed: 30637550
Br J Cancer. 2017 Nov 7;117(10):1427-1441
pubmed: 28982110
Ann Surg Oncol. 2019 Dec;26(13):4587-4598
pubmed: 31605342
BMJ Open Gastroenterol. 2018 Jul 27;5(1):e000217
pubmed: 30073092
BMC Cancer. 2019 Aug 29;19(1):857
pubmed: 31464611
J Oncol Pract. 2016 Jan;12(1):6-10
pubmed: 26759458
J Pathol Clin Res. 2018 Oct;4(4):227-240
pubmed: 29917326
Memo. 2018;11(3):172-179
pubmed: 30220923

Auteurs

Ali Bohlok (A)

Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Peter Vermeulen (P)

Translational Cancer Research Unit, GZA Hospitals & CORE, MIPRO, University of Antwerp, Antwerp, Belgium.
Department of Oncological Research, Oncology Center, GZA Hospitals Sint-Augustinus, Antwerp, Belgium.

Sophia Leduc (S)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Emily Latacz (E)

Translational Cancer Research Unit, GZA Hospitals & CORE, MIPRO, University of Antwerp, Antwerp, Belgium.

Lara Botzenhart (L)

Department of Oncological Research, Oncology Center, GZA Hospitals Sint-Augustinus, Antwerp, Belgium.

François Richard (F)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Maxim De Schepper (M)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Tatjana Geukens (T)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium.

Valerio Lucidi (V)

Department of Abdominal Surgery, Hôpital Erasme, Université Libre de Bruxelles, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Michail Ignatiadis (M)

Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Philippe Aftimos (P)

Clinical Trials Conduct Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Christos Sotiriou (C)

Breast Cancer Translational Lab, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Martine Piccart (M)

Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Alain Hendlisz (A)

Medical Oncology Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Steven Van Laere (S)

Translational Cancer Research Unit, GZA Hospitals & CORE, MIPRO, University of Antwerp, Antwerp, Belgium.

Luc Dirix (L)

Translational Cancer Research Unit, GZA Hospitals & CORE, MIPRO, University of Antwerp, Antwerp, Belgium.
Department of Oncological Research, Oncology Center, GZA Hospitals Sint-Augustinus, Antwerp, Belgium.

Jean-Christophe Noël (JC)

Department of Pathology, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Elia Biganzoli (E)

Department of Clinical Sciences and Community Health & DSRC, University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Denis Larsimont (D)

Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.

Christine Desmedt (C)

Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium. christine.desmedt@kuleuven.be.

Vincent Donckier (V)

Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. vincent.donckier@bordet.be.

Classifications MeSH